NIH-funded research U01 cooperative agreement

Ultrasound method to break up and drain brain clots from bleeding strokes

Official title: Novel Ultrasonic Technique for the Treatment of Hemorrhagic Stroke

Funded at University of Michigan at Ann Arbor · NIH-11057991 · Data updated 2026-11-12

Using focused ultrasound through the skull to liquefy and drain blood clots for people with intracerebral hemorrhage (bleeding stroke).

More Stroke research and trials

Quick facts

Grant typeU01 cooperative agreement
Study typeNIH-funded research
Funding institutionUniversity of Michigan at Ann Arbor
NIH-funded
Lab location1 site (Ann Arbor, United States)
Project startSeptember 30, 2018
Project endJune 30, 2030
Funding year2025
Award (this year)$683,855
NIH project number2U01NS108042-06A1
Project IDNIH-11057991 on NIH RePORTER

Who could benefit from this research

Could help

Adults with an acute intracerebral hemorrhage (bleeding stroke) whose clot size and location make them eligible for minimally invasive clot drainage and who meet safety criteria.

Less likely to help

People with very small or widely scattered bleeds, unstable medical conditions, uncontrolled bleeding disorders, or clots in locations that cannot be safely targeted may not benefit or be eligible.

What this research studies

If I had a bleeding stroke caused by a clot inside my brain, this project would use a guided focused‑ultrasound system placed outside my skull to break up the clot. The ultrasound pulses (histotripsy) create tiny bubbles that quickly liquefy the clot without clot‑busting drugs or large open surgery. The liquefied clot would then be removed through a small catheter to reduce damage to normal brain tissue and lower the chance of rebleeding. The team has built a prototype NaviTH system and is working to make it safe and ready for patient use.

Why it matters

Potential benefit: Could allow faster clot removal with less damage to healthy brain tissue, improving recovery after hemorrhagic stroke.

How similar studies have gone: Other minimally invasive clot‑removal approaches have shown benefit in trials, while histotripsy is a newer ultrasound‑based method with promising preclinical and early feasibility results.

Where this research is happening

  • University of Michigan at Ann Arbor
    Ann Arbor, United States
    Active

Researchers

  • Principal investigator: Pandey, Aditya S — University of Michigan at Ann Arbor
  • Study coordinator: Pandey, Aditya S

Related research

Other NIH-funded projects on the same topics.

  • Cross-talk between SARM1-driven axon damage and ferroptosis in brain hemorrhage

    A study in people with brain bleeding (intracerebral hemorrhage) to understand how axons get damaged and how iron-related cell death contributes to disability.

    NIH research Suny Downstate Medical Center · Brooklyn, United States · NIH-11600981

  • Recombinant factor VIIa given very early for bleeding stroke

    This trial gives a clotting medicine called rFVIIa very soon after a spontaneous brain bleed to adults to try to improve recovery.

    NIH research University of Cincinnati · Cincinnati, United States · NIH-11473255

  • Early Factor VIIa treatment for bleeding stroke

    This project tests whether giving a clotting medicine called recombinant Factor VIIa very soon after a spontaneous brain bleed helps adults recover better than standard care alone.

    NIH research University of Cincinnati · Cincinnati, United States · NIH-11473147

  • Early clotting-factor treatment for sudden brain bleed

    This research gives a clotting medicine called rFVIIa very soon after a sudden brain bleed to see whether people with intracerebral hemorrhage do better than with standard care alone.

    NIH research University of Cincinnati · Cincinnati, United States · NIH-11473146

  • Ultrasound method to safely treat brain bleeds without open surgery

    A new ultrasound-based technique aims to liquefy and drain intracerebral hemorrhage through the skull in a minimally invasive way.

    NIH research University of Michigan at Ann Arbor · Ann Arbor, United States · NIH-11379522

  • Early Factor VIIa treatment for bleeding stroke

    This research compares early intravenous recombinant Factor VIIa plus usual care with usual care alone for people who have a sudden brain bleed (intracerebral hemorrhage) to try to improve recovery.

    NIH research University of Cincinnati · Cincinnati, United States · NIH-11286770

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.